Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial
Titel:
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial
Auteur:
Dytfeld, Dominik Wróbel, Tomasz Jamroziak, Krzysztof Kubicki, Tadeusz Robak, Paweł Walter-Croneck, Adam Czyż, Jarosław Tyczyńska, Agata Druzd-Sitek, Agnieszka Giannopoulos, Krzysztof Nowicki, Adam Szczepaniak, Tomasz Łojko-Dankowska, Anna Matuszak, Magdalena Gil, Lidia Puła, Bartosz Rybka, Justyna Majcherek, Maciej Usnarska-Zubkiewicz, Lidia Szukalski, Łukasz Końska, Agnieszka Zaucha, Jan Maciej Walewski, Jan Mikulski, Damian Czabak, Olga Robak, Tadeusz Lahoud, Oscar B Zonder, Jeffrey A Griffith, Kent Stefka, Andrew Major, Ajay Derman, Benjamin A Jakubowiak, Andrzej J